Mass. bureaucrats, 'Boston Legal' wrong about EC

February 16, 2006 09:00 AM

So-called emergency contraception is a risky drug
regimen that can take the life of a newly formed human person," said Judie Brown, president of American Life League. "The decision in Massachusetts forcing pharmacies to sell this potentially lethal product is just one more example of the culture of death in our society. The additional misinformation presented in Tuesday night's episode of the 'Boston Legal' program only serves to compound the damage by misleading viewers, who are not provided with an accurate account of the drug's effects."

A recent decision by the Massachusetts Board of Pharmacy, which oversees contraception laws, now forces all Massachusetts pharmacies to fill Plan B ? commonly known as emergency contraception ? regardless of pharmacists' moral objections. The fictional courtroom of "Boston Legal" added fuel to the fire by suggesting that Catholic teaching about the morning-after pill is an example of religious obstructionism that must be overcome ? through the legal system, if necessary.

American Life League opposes the morning-after pill because one of the mechanisms for use is the hardening of the uterine wall which can prevent a newly formed human embryo from implanting in its mother's womb. "The bottom line is, Plan B can kill, and the government should never sanction abortion of any kind," said Mrs. Brown. "Because of this simple fact, it should have never been approved by the FDA."

She also expressed dismay that not some of the pro-life movement's most prominent voices are silent on the subject of the morning-after pill. "The manufacturer states quite clearly that one of this drug's modes of actions results in the ending of a newly-created human
being's life. Why is it that some of the very people who are dedicated to ending abortion cannot see that this, too, is an assault on an innocent person? I would hope that they examine the facts, pause and reflect, and add their voices to the call for immediate removal of this deadly drug from the market."

Release issued: 16 Feb 06

Back to news